This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group, enhances the metabolic stability and bioavailability of drug molecules, making it valuable in the development of drugs targeting central nervous system disorders, pain management, and other therapeutic areas. Additionally, it serves as a key intermediate in asymmetric synthesis, enabling the production of enantiomerically pure compounds, which are crucial for ensuring the efficacy and safety of chiral drugs. Its application extends to research and development, where it is used to explore new chemical entities and optimize drug candidates.